These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28341099)

  • 41. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran.
    Hasani A; Sheikhalizadeh V; Ahangarzadeh Rezaee M; Rahmati-Yamchi M; Hasani A; Ghotaslou R; Goli HR
    Microb Drug Resist; 2016 Jul; 22(5):347-53. PubMed ID: 26779992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii.
    Sheikhalizadeh V; Hasani A; Ahangarzadeh Rezaee M; Rahmati-Yamchi M; Hasani A; Ghotaslou R; Goli HR
    J Infect Chemother; 2017 Feb; 23(2):74-79. PubMed ID: 27889248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Ušjak D; Ivković B; Božić DD; Bošković L; Milenković M
    Microb Pathog; 2019 Jun; 131():186-196. PubMed ID: 30980878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran.
    Malekzadegan Y; Abdi A; Heidari H; Moradi M; Rastegar E; Sedigh Ebrahim-Saraie H
    BMC Res Notes; 2019 May; 12(1):301. PubMed ID: 31138309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J; Hirai CK; Takenaka IM
    J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Watanakunakorn C
    Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
    Keen EF; Murray CK; Robinson BJ; Hospenthal DR; Co EM; Aldous WK
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):728-32. PubMed ID: 20500036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
    Xirouchaki E; Giamarellou H
    J Chemother; 1992 Oct; 4(5):263-7. PubMed ID: 1479414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
    J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.
    Lee H; Roh KH; Hong SG; Shin HB; Jeong SH; Song W; Uh Y; Yong D; Lee K
    Ann Lab Med; 2016 Mar; 36(2):138-44. PubMed ID: 26709261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
    Clark RB; Sanders CC; Pakiz CB; Hostetter MK
    Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens from Germany.
    Kresken M; Korte-Berwanger M; Gatermann SG; Pfeifer Y; Pfennigwerth N; Seifert H; Werner G
    Int J Antimicrob Agents; 2020 Oct; 56(4):106128. PubMed ID: 32758648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of amikacin, gentamicin and tobramycin combined with carbenicillin or ticarcillin against Pseudomonas aeruginosa in vitro.
    Meitert E; Petrescu AM; Chiru M
    Arch Roum Pathol Exp Microbiol; 1985; 44(2):127-36. PubMed ID: 3938268
    [No Abstract]   [Full Text] [Related]  

  • 60. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
    Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
    Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.